Video Preview
🎧 Podcast episode for paid subscribers only. Also available on Apple Podcasts and Spotify.
To listen to paid episodes in Apple or Spotify, link your Substack subscription via the show settings on those platforms (instructions inside the Substack app under Subscriptions → Podcast).
Table of Contents
1. The thesis in plain English
2. Why the billing unit decides who gets hurt
3. The five legacy models with a target on their back
4. Two near misses: pharma document shops and CRO back offices
5. The five archetypes with a real shot at winning
6. Diagnostics and care management, where it is augmentation and not replacement
7. Who actually keeps the savings
8. Five things that would change the rankings
9. The base case through 2029
Abstract
- AI is not killing healthcare services. It is deleting minutes from discrete, documented, rules-heavy tasks: typing, extraction, routing, status checks, first drafts, coding suggestions, first-pass review.
- That breaks any vendor priced per FTE, per line, per page, per case or per transaction, because the buyer gets the first dollar of savings and then asks for a lower price, insources, or buys the workflow from the EHR or payer core platform.
- Most exposed, in order: labor-only transcription and synchronous scribing; commodity RCM, coding and claims follow-up BPO; routine patient access and contact centers; payer intake, prior auth and routine UM ops; generic HIT staff aug and document factories.
- Best positioned: end-to-end RCM managed services that own exceptions and price on outcomes; hybrid AI plus human documentation and access ops sold as a result; licensed-human payer ops and payment integrity with audit trails; specialist interoperability and managed AI operations; AI assurance, security, clinical validation and regulated biopharma delivery.
- Pharma document factories and CRO back offices carry very high task exposure but only moderate business exposure through 2029, because GxP sign-off, scientific judgment and physical site work stay stubbornly human.
- Diagnostics, care management and specialty pharmacy support are augmentation first. The money goes to whoever holds the integrations, the outcome data, the exception queue and the contract language.
- Five tells to watch: independently audited production evidence, contract migration away from FTE pricing, platform absorption by EHR and payer cores, policy execution on CMS-0057-F and the HIPAA Security Rule NPRM, and longitudinal safety and equity data.
